Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA)-4 Mutation in EBV-Associated Malignancies in Three Different Populations

This publication has 52 references indexed in Scilit:

• Population Dynamics of Immune Responses to Persistent Viruses
  Science, 1996
• The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
  The Journal of Experimental Medicine, 1996
• Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules
  Immunity, 1995
• T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
  The Journal of Experimental Medicine, 1994
• Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
  The Journal of Experimental Medicine, 1993
• PCR amplification of specific alleles: Rapid detection of known mutations and polymorphisms
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
• HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 ⁺ Population
  Science, 1993
• Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
  The Journal of Experimental Medicine, 1992
• Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
  The Journal of Experimental Medicine, 1992
• T-cell antigen receptor genes and T-cell recognition
  Nature, 1988